Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials

Rivera, Frederick Berro; Cruz, Linnaeus Louisse A.; Magalong, John Vincent; Ruyeras, Jade Monica Marie J.; Aparece, John Paul; Bantayan, Nathan Ross B.; Lara-Breitinger, Kyla; Gulati, Martha

doi:10.1016/j.ajpc.2024.100679

American Journal of Preventive Cardiology

2024

DOI: 10.1016/j.ajpc.2024.100679

|View full text |Cite

Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials

Frederick Berro Rivera,

Linnaeus Louisse A. Cruz,

John Vincent Magalong

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis

Bosco,

Di Giacomo Barbagallo,

Di Marco

et al. 2024

European Journal of Internal Medicine

View full text Add to dashboard Cite

Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis

Bosco,

Di Giacomo Barbagallo,

Di Marco

et al. 2024

European Journal of Internal Medicine

View full text Add to dashboard Cite

Enrollment of Females in Randomized Trials for Glucagon-Like Peptide 1 Receptor Agonists

Rivera,

Ybañez,

Magalong

et al. 2024

JACC: Advances

View full text Add to dashboard Cite

To the Brain and Beyond: Neurological Implications of Glucagon-Like Peptide-1 Receptor Agonists

Hunter Guevara,

Beam,

Pasternak

2024

Journal of Neurosurgical Anesthesiology

View full text Add to dashboard Cite

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as an increasingly popular class of medications commonly used for glycemic control in patients with type 2 diabetes mellitus and for weight loss. GLP-1 RAs also have potential benefits in patients with various neurological diseases independent of their glucose-modulating effect. In this focused review, we explore animal and clinical evidence evaluating the impact of GLP-1 RAs in common neurological diseases. Our aim is to provide a basis for hypothesis generation for future studies to assess the role that GLP-1 RAs may have on the nervous system, including implications for the perioperative period.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials

Cited by 6 publications

References 42 publications

Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis

Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis

Enrollment of Females in Randomized Trials for Glucagon-Like Peptide 1 Receptor Agonists

To the Brain and Beyond: Neurological Implications of Glucagon-Like Peptide-1 Receptor Agonists

Contact Info

Product

Resources

About